An Indispensible Parameters of Trandolapril Include Indications, Pharmaco Dynamics, Actions, Route of Excretion, Half-Life Toxicity and Interactions

Trandolapril is a non-sulfhydryl prodrug that is associated with the angiotensin-converting enzyme (ACE) inhibitor of medications. It is metabolized to its biologically active diacid form, trandolaprilat, especially in the liver. The enzyme ACE, which is necessary for the transformation of angiotensin I (ATI) into angiotensin II (ATII), is inhibited by trendolaprilat. A vital part of the renin-angiotensin-aldosterone system (RAAS), ATII regulates blood pressure. Trandolapril plays an important role regarding treatment of mild to moderate hypertension, to promote survival following myocardial infarction in stable patients in a clinical manner along with left ventricular dysfunction, as an adjunct treatment for congestive heart failure, and to reduce the rate of progression of renal disease in hypertensive individuals along with diabetes mellitus and microalbuminuria or overt nephropathy.